Jefferies Upgrades Regeneron Pharmaceuticals to Hold, Raises Price Target to $675
Jefferies analyst Akash Tewari upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) from Underperform to Hold and raises the price target from $536 to $675.
JP Morgan Upgrades Spire to Overweight, Raises Price Target to $78
JP Morgan analyst Richard Sunderland upgrades Spire (NYSE:SR) from Neutral to Overweight and raises the price target from $74 to $78.
JP Morgan Upgrades American Water Works to Neutral, Raises Price Target to $165
JP Morgan analyst Richard Sunderland upgrades American Water Works (NYSE:AWK) from Underweight to Neutral and raises the price target from $162 to $165.
Citigroup Upgrades ResMed to Buy
Citigroup analyst John Deakin-Bell upgrades ResMed (NYSE:RMD) from Neutral to Buy.
Goldman Sachs Expects Solar Stocks To Continue Shining: Here Are The Biggest Beneficiaries Of The Inflation Reduction Act
Solar stocks traded significantly higher over the past month following the passage of the Inflation Reduction Act, which included several investments in clean energy.
Wolfe Research Upgrades World Wrestling Enter to Outperform, Announces $98 Price Target
Wolfe Research analyst Peter Supino upgrades World Wrestling Enter (NYSE:WWE) from Peer Perform to Outperform and announces $98 price target.
CJS Securities Upgrades John Wiley & Sons to Market Outperform
CJS Securities analyst Daniel Moore upgrades John Wiley & Sons (NYSE:WLY) from Market Perform to Market Outperform.
Morgan Stanley Upgrades Hexcel to Equal-Weight, Raises Price Target to $68
Morgan Stanley analyst Kristine Liwag upgrades Hexcel (NYSE:HXL) from Underweight to Equal-Weight and raises the price target from $59 to $68.
Pivotal Research Upgrades Roku to Hold, Announces $60 Price Target
Pivotal Research analyst Jeffrey Wlodarczak upgrades Roku (NASDAQ:ROKU) from Sell to Hold and announces $60 price target.